Florou Vasiliki, Kamargiannis Nikos, Bizakis Ioannis, Skoulakis Charalampos, Hajiioannou Jiannis
ENT Department, "G Gennimatas" General Hospital, Thessaloniki, Greece.
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
Maedica (Bucur). 2024 Sep;19(3):486-493. doi: 10.26574/maedica.2024.19.3.486.
Laryngopharyngeal reflux (LPR) is responsible for many otorhinolaryngology manifestations. There is little evidence regarding the LPR impact on olfaction. No other study has investigated the efficacy of proton pump inhibitors (PPIs) on olfaction. We aimed to evaluate the effect of antireflux medication on olfaction and nasal patency in patients with LPR.
Thirty patients with LPR were recruited. Nasal symptoms were self-evaluated with NOSE and SNOT-22 surveys, while a taste visual analogue scale (VAS) was used for gustation. Olfaction was evaluated with Sniffin' Sticks test and nasal patency with anterior rhinomanometry. After 12 weeks of oral PPIs, the procedure was re-applied and clinical outcomes were compared.
Variables with statistically significant difference included the olfactory threshold (means 1,87/ SD 3,3/ t -3,11/ p 0,004) and the combined threshold-discrimination-identification (TDI) scores of Sniffin' Sticks test (means -2,61/ SD 5.26/ t -2.75/ p 0.01) and the self-assessment NOSE (p 0.009) and SNOT-22 (0.031) tests. However, no variable concerning nasal patency revealed statistically significant difference before and after treatment in the study group (p 0.677).
Oral PPIs treatment was associated with better olfactory threshold and TDI scores. These results raise the need for further studies, regarding the effect of antireflux medication on patients suffering from LPR who express nasal symptoms and olfaction disfunction.
喉咽反流(LPR)是许多耳鼻咽喉科表现的病因。关于LPR对嗅觉影响的证据很少。没有其他研究调查过质子泵抑制剂(PPI)对嗅觉的疗效。我们旨在评估抗反流药物对LPR患者嗅觉和鼻通气的影响。
招募了30例LPR患者。通过NOSE和SNOT - 22问卷进行鼻症状自评,同时使用味觉视觉模拟量表(VAS)评估味觉。用嗅棒测试评估嗅觉,用前鼻测压法评估鼻通气。口服PPI 12周后,重复上述操作并比较临床结果。
具有统计学显著差异的变量包括嗅阈值(均值1.87/标准差3.3/t - 3.11/p 0.004)、嗅棒测试的综合阈值 - 辨别 - 识别(TDI)评分(均值 - 2.61/标准差5.26/t - 2.75/p 0.01)以及自我评估的NOSE(p 0.009)和SNOT - 22(0.031)测试。然而,研究组中关于鼻通气的变量在治疗前后未显示出统计学显著差异(p 0.677)。
口服PPI治疗与更好的嗅阈值和TDI评分相关。这些结果表明需要进一步研究抗反流药物对有鼻症状和嗅觉功能障碍的LPR患者的影响。